Colorectal Cancer

Cancer of the colon or rectum. Trials span screening, adjuvant therapy, and metastatic disease.

65.4%

5-year relative survival

U.S. average across all stages

300

recruiting trials

Active in the U.S. right now

154,270

new diagnoses / year

You are not alone — roughly 423 people per day

median age at diagnosis

Most diagnoses occur in adults over age 50

Colorectal Cancer by the numbers (U.S.)

154,270

Estimated new cases (2025)

52,900

Estimated deaths (2025)

65.4%

5-year relative survival

Median age at diagnosis

300 actively recruiting trials across the U.S., with filters by state.

Every FDA-approved therapy with colorectal cancer in its indications — mechanisms, Medicare spending per drug, manufacturer assistance.

CMS Medicare spending data for 15 major oncology drugs — what patients and Medicare actually pay.

What to test at diagnosis, and which targeted therapies each biomarker unlocks.

Step-by-step for getting a virtual second opinion from a top cancer center.

All 71 NCI cancer centers with hospital quality data and state browser.

Licensed oncologists across every U.S. state, by specialty.

Co-pay relief, drug patient-assistance, transportation, and lodging support.

How to read a pathology report, questions to ask your oncologist, staging explained.

colon cancer, rectal cancer.

See the NCI SEER Cancer Stat Facts page: Colorectal Cancer on SEER →